Publications by authors named "Thomas Ervin"

Claim this Profile
F
Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia.
Jeff P Sharman, Steven E Coutre, Richard R Furman, Bruce D Cheson, John M Pagel, Thomas Ervin

J Clin Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First-Line Nonsquamous Non-Small Cell Lung Cancer.
Joachim von Pawel, David R Spigel, Thomas Ervin, György Losonczy, Fabrice Barlesi

Oncologist· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Richard R Furman, Jeff P Sharman, Steven E Coutre, Bruce D Cheson, John M Pagel, Thomas Ervin

N Engl J Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
David R Spigel, Thomas J Ervin, Rodryg A Ramlau, Davey B Daniel, Jerome H Goldschmidt

J Clin Oncol· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.
Daniel D Von Hoff, Thomas Ervin, Francis P Arena, E Gabriela Chiorean, Jeffrey Infante

N Engl J Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment rationale and study design for a randomized, double-blind, placebo-controlled phase II study evaluating onartuzumab (MetMAb) in combination with bevacizumab plus mFOLFOX-6 in patients with previously untreated metastatic colorectal cancer.
Johanna C Bendell, Thomas J Ervin, David Gallinson, Jaswinder Singh, James A Wallace

Clin Colorectal Cancer· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized phase II trial of pemetrexed/gemcitabine/bevacizumab or pemetrexed/carboplatin/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.
David R Spigel, John D Hainsworth, Dianna L Shipley, Thomas J Ervin, Peter C Kohler

J Thorac Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme.
John D Hainsworth, Thomas Ervin, Elke Friedman, Victor Priego, Patrick B Murphy

Cancer· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer.
Marshall R Posner, Diane M Hershock, Cesar R Blajman, Elizabeth Mickiewicz, Eric Winquist, Thomas J Ervin

N Engl J Med· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis